MIMEDX to Participate in Upcoming Investor Conferences
MIMEDX (MDXG) announced that senior management will participate in the Canaccord investor forum in New York on November 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MIMEDX (MDXG) announced that senior management will participate in the Canaccord investor forum in New York on November 11, 2026. The MedTech, Diagnostics and Digital Health & Services Forum includes one-on-one sessions and a 9:00 am EST presentation. Management will also hold one-on-one sessions at the Craig-Hallum 17th Annual Alpha Select Conference in New York on November 17, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MARIETTA, Ga., Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Canaccord MedTech, Diagnostics and Digital Health & Services Forum | New York, NY
Wednesday, November 11, 2026
1:1 sessions + presentation (9:00 am EST): webcast
Craig-Hallum 17th Annual Alpha Select Conference | New York, NY
Tuesday, November 17, 2026
1:1 sessions
Investors interested in meeting with senior management at these events may contact their respective Canaccord or Craig-Hallum representative.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
